Latest Insights - page 32 | BiopharmaTrend

Kvantify Taps Gefion AI Supercomputer to Scale Quantum Chemistry Simulations for Drug Discovery

As reported by The Quantum Insider, Kvantify, a Denmark-based quantum software firm focused on chemistry and drug discovery, has become the first dedicated quantum company to deploy the Gefion AI …

Continue ›››

Dutch Startup CryoCloud Lands €2M to Automate Cryo-EM for Drug Discovery

Dutch startup CryoCloud, a provider of cloud-native tools for cryo-electron microscopy (cryo-EM) data analysis, has raised €2M in seed funding to further develop its automation-first SaaS platform. The round was …

Continue ›››

Lantern Pharma Gets FDA Green Light for AI-Guided Trial Targeting Hard-to-Treat Lung Cancer

The company’s second Phase 1b/2 trial of LP-184 within a month will test the AI-developed small molecule in patients with lung tumors that resist standard treatments.

Continue ›››

OpenAI Introduces Open Benchmark To Assess AI Performance in Realistic Healthcare Scenarios

OpenAI has released HealthBench, an open-source benchmark developed with 262 physicians across 60 countries to evaluate large language models (LLMs) in realistic healthcare interactions. The benchmark includes 5,000 multilingual, multi-turn conversations …

Continue ›››

AI Drug Discovery Company Insilico Medicine Makes Third Bid for Hong Kong IPO

Insilico Medicine has filed again for an IPO on the Hong Kong Stock Exchange (HKEX), marking its third attempt following the one in September 2024. The company is seeking to …

Continue ›››

Toronto’s Intrepid Labs Emerges with $11M and AI-Driven Platform to Rebuild Drug Formulation R&D

Toronto-based Intrepid Labs has emerged from stealth with $11 million in total funding to commercialize its autonomous drug formulation platform, Valiant. Designed to overhaul conventional formulation workflows, Valiant combines machine …

Continue ›››

Scientists Engineer Precision Tool for Mitochondrial DNA Manipulation

A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA (mtDNA) in patient-derived stem cells, offering a new method to …

Continue ›››

Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial

Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from the Netherlands Enterprise Agency, alongside additional funding from its existing …

Continue ›››

Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace

Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration with Amazon Web Services (AWS) by becoming an "Advanced Technology …

Continue ›››

Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use

At the 2025 Annual Meeting of the American Association for Cancer Research (AACR)—a major international conference focused on cancer science and therapeutic development—Crown Bioscience, a preclinical contract research organization specializing …

Continue ›››

Moderna to Onboard R&D Teams to Benchling Platform for AI-Driven Research Integration

Benchling is expanding its collaboration with Moderna, which is now adopting the platform across its broader research organization. The rollout aims to unify experiment design, sample tracking, and results analysis …

Continue ›››

Startup Working with Italian Hospitals Raises €2.2M to Structure Medical Reports into Care Plans

Milan-based startup ReportAId has raised €2.2 million in pre-seed funding to develop its AI platform aimed at converting unstructured medical reports into structured, actionable care plans. The round was led …

Continue ›››